Core Scientific Inc. (NASDAQ: CORZ) is positioned to capitalize on the growing demand for AI infrastructure as its partner, CoreWeave, advances a major expansion in Texas. This development is closely tied to a significant contract with OpenAI, which is driving increased need for high-performance computing resources.
CoreWeave’s Expansion at Texas Site
In early 2025, Core Scientific announced a $1.2 billion expansion at its Denton, Texas facility. This expansion aims to increase the company’s high-performance computing capacity to approximately 590 megawatts across six sites. CoreWeave is utilizing this infrastructure to build one of the largest GPU supercomputers in North America, positioning both companies at the forefront of AI technology support.
OpenAI Partnership Strengthens CoreWeave’s Growth
CoreWeave’s collaboration with OpenAI is a major catalyst behind this expansion. OpenAI has committed up to $12 billion over five years to leverage CoreWeave’s infrastructure. Additionally, OpenAI has made a $350 million equity investment in CoreWeave, signaling strong confidence in their partnership and the future of AI infrastructure development.
What This Means for Core Scientific’s Stock
Bernstein analysts have maintained an “Outperform” rating on Core Scientific, citing the positive impact of CoreWeave’s growth and the rising demand for AI computing power. Investors are advised to watch Core Scientific’s stock closely as the company benefits from the expansion and its ties to the OpenAI contract.
Conclusion
The progress at CoreWeave’s Texas site tied to OpenAI represents a significant growth opportunity for Core Scientific. With AI technologies expanding rapidly, Core Scientific is well-positioned to ride the wave of increased infrastructure demand. Investors looking for exposure to AI-related stocks should consider monitoring Core Scientific closely.

